Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

IBN SINA Pharmaceutical Industry Ltd (TISN)

DSE
Currency in BDT
Disclaimer
253.70
+0.70(+0.28%)
Closed
TISN Scorecard
Trading near 52-week Low
Fair Value
Unlock Value
Day's Range
250.00259.00
52 wk Range
250.00290.00
Prev. Close
253
Open
259
Day's Range
250-259
52 wk Range
250-290
Volume
23,558
Average Volume (3m)
14,321
1-Year Change
-11.48%
Shares Outstanding
31,243,627
Fair Value
Unlock
Dividends Payment Streak
Unlock
Analysts
Technical
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
How do you feel today about TISN?
Vote to see community's results!
or

IBN SINA Pharmaceutical Industry Ltd Company Profile

The IBN SINA Pharmaceutical Industry PLC produces and sells pharmaceutical drugs in Bangladesh and internationally. The company provides its products in various forms, such as solid dosage forms consisting of tablets and capsules; parenteral products covering ampoules and vials; liquid dosage forms comprising syrups, solutions, suspensions, and powder for suspension (dry syrups); and sterile ophthalmic products, creams, ointments, gels, eye drops and sachet, etc. It also offers various therapeutic products, including analgesic and anti-inflammatory, anti-allergic-occular, anti-arthritis supplement, anti-asthmatic, anti-emetic, anti-fibrinolytic, anti-fungal, anti-glucoma, anti-histamine, anti-malarial, anti-melasma, anti-neuropathic, anti-protozoal, anti-spasmodic, anti-ulcerant, antibacterial, antibiotic, anticataract, anti-diabetic, antigout, anti-helmintic, antimigraine agent, antisecretory, antivertigo agent, and antiviral products. In addition, the company’s therapeutic products comprise antibiotic and steroid, antibiotic-occular, antifungal-occular, antiviral-occular, anxiolytic and antidepressant, aromatase inhibitor, bile acid, bisphosphonates, calcium supplement, cardiovascular preparation, cholinesterase inhibitor, corticosteroid, cough expectorant, dry eye syndrome, gastroprokinetic agent, haematinic/vitamin and mineral, hand rub, hormone products, intestinal anti-inflammatory, laxative, multivitamin and multi-minerals, muscle relaxant, mydriatic agents, nasal decongestant, neuroleptic, nootropic, NSAIDS, NSAIDS-occular, ORS, steroid-occular, topical, urinary incontinence, and sodium-glucose co-transporter inhibitor products. Further, it provides herbal and Unani products; and manufactures and trades in active pharmaceutical ingredients, natural medicines, polymer plastic bottles, plastic tubes, laminated tubes, and other related products. The IBN SINA Pharmaceutical Industry PLC was incorporated in 1983 and is headquartered in Dhaka, Bangladesh.

Employees
4000
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.